1-4 of 4
Jiro Kitaura, MD
Close
Sort by
Journal Articles

A Patient-Derived EZH2 Mutant Induces MDS-like Diseases with Derepressed ABCG2 Expression in Mice

Kimihito Cojin Kawabata, MD PhD, Daichi Inoue, MD PhD, Jiro Kitaura, MD PhD, Yuka Harada, MD PhD, Susumu Goyama, MD PhD, Hironori Harada, MD PhD, Hiroyuki Aburatani, MD PhD, Toshio Kitamura, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4116.
https://doi.org/10.1182/blood.V126.23.4116.4116
Published: 2015
Journal Articles

SETBP1 Mutations Drive Leukemic Transformation in ASXL1 -Mutated MDS

Daichi Inoue, MD PhD, Hirotaka Matsui, MD PhD, Hsin-An Hou, MD PhD, Wen-Chien Chou, MD PhD, Akiko Nagamachi, PhD, Jiro Kitaura, MD PhD, Kimihito Cojin Kawabata, MD PhD, Katsuhiro Togami, MD PhD, Reina Nagase, Sayuri Horikawa, Makoto Saika, MD, Jean-Baptiste Micol, MD, Yasutaka Hayashi, MD, Yuka Harada, MD PhD, Hironori Harada, MD PhD, Hwei-Fang Tien, MD PhD, Omar Abdel-Wahab, MD, Toshio Kitamura, MD PhD
Journal: Blood
Blood (2014) 124 (21): 525.
https://doi.org/10.1182/blood.V124.21.525.525
Published: 2014
Journal Articles

Analysis of Mouse LMIR5/CLM-7 as An Activating Receptor: Differential Regulation of LMIR5/CLM-7 in Mouse Versus Human Cells

Yoshinori Yamanishi, MD, PhD, Jiro Kitaura, MD, Kumi Izawa, MD, Toshihiko Oki, MD, PhD, Toshiyuki Takai, PhD, Toshio Kitamura, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4639.
https://doi.org/10.1182/blood.V112.11.4639.4639
Published: 2008
Journal Articles

A BMT Model Mice for Myelodysplastic Syndromes (MDS) and Transformation to AML.

Naoko Watanabe-Okochi, MD, Jiro Kitaura, MD, Hironori Harada, PHD, Ryoichi Ono, PHD, Hideaki Nakajima, PHD, Tetsuya Nosaka, PHD, Toshiya Inaba, PHD, Toshio Kitamura, PHD
Journal: Blood
Blood (2006) 108 (11): 2633.
https://doi.org/10.1182/blood.V108.11.2633.2633
Published: 2006